Dow Jones Newswires: AstraZeneca’s Covid-19 vaccine gets EU approval for third doses

AstraZeneca PLC said Monday that its Covid-19 vaccine has been granted approval in the European Union as a third dose booster for adults.

Previous post Dow Jones Newswires: German business confidence unexpectedly rose in May, Ifo says
Next post Dow Jones Newswires: India steel stocks fall sharply after government announces export levy